All the information regarding the initial reprising of stock options is available in the Management Proxy Solicitation Circular dated April 7, 2011 that is available on SEDAR at www.sedar.com or on DEQ’s website in the Invest/Corporate Information section.
A total of 3,935,000 stock options with an exercise price between US$ 0.46 and US$ 1.45 per share, with expiry dates between 2014, and 2019, will be reprised at an exercise price of US$ 0.42.
Earle G. Hall, President and CEO of DEQ reports: “The market reaction to the acceleration in our product placement has prompted the Board of Directors to increase the exercise price of the reprising to US$ 0.42 to ensure that DEQ demonstrates the proper respect for our shareholders.”
In accordance with TSX Venture Exchange policies, the reprising of any options held by officers and directors of a company is subject to disinterested shareholders’ approval. Accordingly, disinterested shareholders of the company will be asked to approve the reprising of 3,225,000 stock options held by officers and directors as well as the 710,000 stock options held by employees at DEQ's annual and special meeting scheduled on May 11.